FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Norelgestromin/Ethinyl Estradiol Transdermal System (ORTHO EVRA)
Status: Discontinuation
»Therapeutic Categories:

Expand all

Janssen Pharmaceuticals (New 10/21/2014)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
ORTHO EVRA (NDC 50458-192-24) 10/21/2014 The decision to discontinue is due to a business decision. Projections indicate that product inventory will deplete at distribution centers at the end of October 2014.
ORTHO EVRA (NDC 50458-192-01) 10/21/2014 The decision to discontinue is due to a business decision. Projections indicate that product inventory will deplete at distribution centers at the end of October 2014.
ORTHO EVRA (NDC 50458-192-15) 10/21/2014 The decision to discontinue is due to a business decision. Projections indicate that product inventory will deplete at distribution centers at the end of October 2014.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English